Arista Networks Inc vs Recursion Pharmaceuticals Inc — how do they compare? Arista Networks Inc trades at $202.75 (market cap $249.53B), while Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.81B). The key difference: Arista Networks Inc is far larger — about 137.9× Recursion Pharmaceuticals Inc's market cap, and Arista Networks Inc is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| ANET | RXRX | |
|---|---|---|
Market Cap | $249.53B | $1.81B |
Sector | Technology | Health |
52-Week High | $197.85 | $6.79 |
52-Week Low | $116.13 | $2.84 |
Enterprise Value | $236.19B | $1.33B |
Trailing returns across standard periods
Latest headlines on both assets
Arista Networks is a software and hardware provider for the networking solutions sector. Operating as one business unit, software, switching, and router products are targeted for high-performance networking applications, while service revenue comes from technical support. Customer markets include data centers, enterprises, service providers, and campuses. The company is headquartered in Santa Clara, California, and generates most of its revenue in the Americas.
Read more on ANET →Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →